LBO — FLOYD MEDICAL CENTER
IRR: 15.9% | MOIC: 2.09x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
15.9%
IRR
2.09x
MOIC
$689.4M
Entry EV
$1.0B
Exit EV
$354.8M
Equity Invested
Sources & Uses
S&UTotal · $689.4M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $267.7M | 38.8% | |
| Sub Debt | $66.9M | 9.7% | |
| Equity | $354.8M | 51.5% | |
| Enterprise Value | $669.3M | 97.1% | |
| Transaction Fees | $20.1M | 2.9% | |
| Total Uses | $689.4M | 100.0% |
Interpretation
INTAt 2.09x MOIC and 15.9% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $96.1M |
| Exit Ev | $1.0B |
| Net Debt At Exit | $268.3M |
| Equity At Exit | $740.6M |
| Equity Invested | $354.8M |
| Total Value Created | $385.9M |
| Value From Growth | $306.1M |
| Value From Multiple | $33.5M |
| Value From Deleveraging | $66.4M |